Interviews - Page 2 of 25 - Express Pharma

Rx-to-OTC is not a channel shift—it’s a complete business model shift

Good pharma-focused developers are now co-designing with GMP/WHO/USFDA consultants from day zero

Local focus to strengthen Indian pharmaceutical manufacturers

India at a jumping-off point in terms of commitment to global clinical studies

Speed and flexibility play a critical role in how we compete with larger global players

Our goal is to help companies reduce cost per cubic meter of wastewater treatment

We train professionals to see quality not as a checklist but as a mindset

Quality Trailblazer emphasises that leadership commitment is non-negotiable

Supriya Lifescience ramps up capacity and global readiness for next phase of growth

We are cost-competitive and aligned with global ESG framework demands